Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Metastatic Malignancies Expressing Carcinoembryonic Antigen

NCT00004604 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00004604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Metastatic Malignancies Expressing Carcinoembryonic Antigen
Lead sponsor
Duke University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 1997
Completion date
July 31, 2002
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, extrahepatic bile duct cancer, gallbladder cancer, gastric cancer, head and neck cancer, liver cancer, lung cancer, metastatic cancer, ovarian cancer, pancreatic cancer, testicular germ cell tumor